[1] RONGYVAUX A, TAKIZAWA H, STROWIG T, et al. Human hemato-lymphoid system mice:current use and future potential for medicine[J]. Annu Rev Immunol, 2013, 31:635-674. [2] SHULTZ L D, BREHM M A, GARCIA-MARTIZNE Z J V, et al. Humanized mice for immune system investigation:progress, promise and challenges[J]. Nat Rev Immunol, 2012,12(11):786-798. [3] TANAKA S, SAITO Y, KUNISAWA J, et al. Development of mature and functional human myeloid subsets in HSC engrafted NOD/SCID/IL2rγKO mice[J]. J Immunol, 2012,188(12):6145-6155. [4] HUNTINGTON N D, LEGRAND N, ALVES N L, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo [J]. J Exp Med, 2009, 206(1):25-34. [5] GIARRATANA M C, KOBARI L, LAPILLONNE H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells[J]. Nat Biotechnol, 2005, 23(1):69-74. [6] ROSENZWAJG B M, CANQUE B, GLUCKMAN J C. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells[J]. Blood, 1996,87(2):535-544. [7] EISENMAN J, AHDIEH M, BEERS C, et al. Interleukin-15 interactions with interleukin-15 receptor complexes:characterization and species specificity[J]. Cytokine, 2002,20(3):121-129. [8] MANZ M G. Human-hemato-lymphoid-system mice:opportunities and challenges[J]. Immunity, 2007,26(5):537-541. [9] NICOLINI F E, CASHMAN J D, HOGGE D E, et al. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration[J]. Leukemia, 2004,18(2):341-347. [10] CHEN Q F, KHOURY M, CHEN J Z. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice[J]. Proc Natl Acad Sci U S A, 2009,106(51):21783-21788. [11] DING S, WU X H, LI G, et al. Efficient transposition of the piggyBac (PB) transposon in mammaliancells and mice[J]. Cell, 2005,122(3):473-483. [12] WILSON M H, COATES C J, GEORGE JR A L. PiggyBac transposon-mediated gene transfer in human cells[J]. Mol Ther, 2007,15(1):139-145. [13] TAGAYA H, SEMBA K, ISHIKAWA K. Genetic manipulation of the mammary gland and potential applications[J]. Oncotarget, 2019, 10(42):4253-4254. [14] YONG M K S, HER Z,CHEN Q F,et al. Humanized mice as unique tools for human-specific studies[J]. Arch Immunol Ther Exp(Warsz), 2018,66(4):245-266. [15] HU Z,VEN ROOIJEN N, YANG Y G. Macrophages prevent human red blood cell reconstitution in immunodeficient mice[J]. Blood, 2011,118(22):5938-5946. [16] JANGALWE S, SHULTZ L D, MATHEW A, et al. Improved B cell development in humanized NOD-scid IL2Rgnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3[J]. Immun Inflamm Dis, 2016, 4(4):427-440. [17] YU H, BORSOTTI C, SCHICKEL J N,et al. A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production[J].Blood, 2017,129(8):959-969. [18] HERNDLER-BRANDSTETTER D, SHAN L, YAO Y, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells[J]. Proc Natl Acad Sci U S A, 2017, 114(45):E9626-E9634. [19] ROSENBERGER C M, CLARK A E, TREUTING P M,et al. ATF3 regulates MCMV infection in mice by modulating IFN-γ expression in natural killer cells[J]. Proc Natl Acad Sci U S A,2008,105(7):2544-2549. [20] CHEN Q F, HE F,KWANG J, et al. GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B and dendritic cell maturation[J]. J Immunol, 2012, 189(11):5223-5229. [21] WILLINGER T, RONGVAUX A, TAKIZAWA H, et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung[J].Proc Natl Acad Sci U S A, 2011,108(6):2390-2395. |